Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals

NCT04946383 is registered in ClinicalTrials.gov with TruDiagnostic as lead sponsor.

NCT NCT04946383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04946383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Effectivness of Quercetin and Dasatinib on the Epigenetic Aging Rates in Healthy Individuals
Lead sponsor
TruDiagnostic
Phase
Phase 2
Overall status
Unknown status
Start date
December 16, 2020
Completion date
June 30, 2022
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging